Israel is blocked for a moment by covid-19 until at least mid-October, but that has not stopped its medical generation industry; in fact, the pandemic has driven demand for some of its products. My interviews with a venture capitalist, a CEO of a public company and two startups reveal two ubiquitous topics:
Olive Tree Ventures invests in fast-growing virtual health companies
Olive Tree Ventures is an Israeli-based venture capital fund that invests in new virtual fitness companies. Olive Tree manages $155 million in assets and has provided capital to nine new companies. See significant opportunities in the virtual fitness box, a market that has grown through 150% since 2017 and is expected to have $540 billion in profits through 2025. Behind this expansion is the generation of industry that improves the rates of diagnosis of serious diseases and develops new remedies for terminal diseases, according to Olive Tree.
Olive Tree’s founder has an impressive delight, typical of many Israeli entrepreneurs. As Amir Lahat, managing spouse of Olive Tree Venture, said in an interview on September 1, “I in the army, not in the 8200. lines — at the age of 20, with more than a hundred people. I studied engineering at Tel Aviv University. 3Com I acquired Telrad, [a company where I was a formula engineer. ] I stayed there for 4 years, then co-founded Atrica, which was supported through Accel and Benchmark. Nokia acquired it [in 2008 for less than $100 million, according to EETimes]. I joined the Business Venture Group in Nokia. Je returned to Israel with 3 young people and founded Olive Tree in 2015 with 3 virtual fitness spouses. »
Olive Tree has invested in corporations that gain advantages from the desire to diagnose and monitor the outdoor fitness of medical practices, a trend that has accelerated through social estating in reaction to the pandemic. “In recent years, there has been a building in the outdoor surveillance and diagnostic tests of medical practices. Our corporations come with TytoCare (which I wrote in May) – which allows patients to perform medical tests at home and send the effects to doctors; ContinUse Biometrics – contactless follow-up of important symptoms in elderly and chronically ill patients, and Scope, virtual microscopy,” he said.
Lemonaid Health, an Olives portfolio company based in San Francisco, seems to me to be booming. Its service allows patients to chat online with a doctor to “give birth or safe prescription drugs to treat undeniable conditions, such as urinary tract infections or erectile dysfunction,” according to the company. Lahat told me. ” Lemonaid is developing incredibly fast, is profitable and operates in 50 states through partnerships with doctors and online drug suppliers. “
Itamar Medical offers faster and less expensive sleep apnea diagnosis
Itamar Medical, a publicly traded medical generation company in Cesarea, Israel, based in the United States in Atlanta, Georgia, that helps doctors diagnose and control sleep apnea. Its key product, WatchPAT, is advertised in the United States, Japan and Europe.
The expansion of Itamar Medical is due to patients seeking a diagnosis and remedy for sleep apnea at home. Revenue for the time being of the 2020 quarter increased by 21% to $8. 9 million, while sales in the US increased by 21% to $8. 9 million, while sales in the US increased by 21% to $8. 9 million. But it’s not the first time Of its disposable sleep apnea device, WatchPAT, increased by 31% to $6. 6 million per quarter, according to the company.
He joined Itamar Medical, founded in Caeseria, Israel, with offices in the United States in Atlanta, Georgia. “When I joined [as CEO in July 2013 at Itamar Medical] a numb, indebted and uns growing company. I sought to fix it The concept of integrating sleep apnea with atrial fibrillation. Sleep apnea affects 15% of the adult population, about 60 million people. When sleep apnea patients fall asleep, their padded tissues collapse, blocking their airlines 10 to 15 times depending on the time. They wake up exhausted, damage the central tissue and is a cause of AF.
Itamar Medical manufactures a device that diagnoses sleep apnea. “We have a medical device that can run into sleep apnea that is less expensive and less complicated for the patient called peripheral arterial tone checkup (PAT). It’s hard to convince the industry to adopt PAT” because sleep doctors weren’t paid for it. Night polysomnography control, in which a patient spends the night in a sleep clinic, will pay the sleep doctor $2,000 while pat costs $200. “
Since 2013, Glick has driven the market capitalization of Itamar Medical. “Since 2013, the company’s market space capitalization has increased from $50 million to [$314 million as of September 18]. I joined because I knew AFib, I think I can create Israeli jobs, and we had no competition. The key to reviving Itamar was to check to convince cardiologists, who are 35,000, [much more than] the 5,000 sleep doctors. We were able to show cardiologists that PAT can help in a threat to the FA. Covid-19, 90% of sleep apnea tests were performed in the sleep clinic, only 10% were performed through PAT. Since Covid-19, sleep labs have closed, which has been a great help to us. “
For more than two and a half years, Itamar has sold a completely disposable PAT check. “One of the first devices sold to doctors. We found that the logistics of a patient returning the $ 200 device to their [expensive] doctor created a completely disposable edition that used a smartphone app to collect and transmit the results. of checks. Since its launch, our sales have grown from $ 3. 5 million to $ 4 million quarterly to $ 10 million in line with the quarter, “Glick said.
Theator helps surgeons make better decisions
Theator operates Minute, a platform that shows the moments of a successful operation, performed through a surgeon of the same experience with a patient in the same condition, before a surgeon is about to perform the operation.
As Tamir Wolf, executive director and co-founder of Theator, explained in an interview on September 15, “I am from Haifa and received a Doctorate in Medicine/Doctorate at Technion. I started working as a doctor on the Israeli equivalent of Seal Team 6. During the Second Lebanon War, I supported a missile-led unit. There were thirteen wounded and I was the only doctor. Operating two of my friends under the retreating chimney. Fortunately, they’re alive. I’ve never experienced this before. What am I doing? You may have used the recommendation of more experienced people.
After a few more years in the army, I needed a break. He went to paint at a medical device company in Cambridge, Massachusetts, and then at Harvard Business School. “To my mother’s disappointment, I made a decision that perhaps simply had a greater effect on a larger scale as an entrepreneur than as a clinician. The challenge he sought to solve materialized through two cases of appendicitis that I dealt with at other hospitals seven miles away in New York. bad decisions since the first, my boss, entered the hospital, almost died; the second, my wife, had abdominal pain; 12 hours after he entered the hospital, he returned home and healed; such far-fetched variability in 2016 made no sense. “
Wolf co-founded Theator in Menlo Park, California, to get results for patients by helping surgeons make more important decisions. “Since the 17th century, surgery has worked in the style of being informed in which Americans receive information from experienced surgeons on how to make smart decisions. The purpose was to provide analyzed surgical photographs, a climax coil that condenses, for example, five hours of surgical video, which can be searched based on the surgeon’s point of experience, medical procedure and patient disease and condition. flagship film to prepare for your next surgery. We have developed a set of rules that annotate everything to create the focus coil for an hour and hour operation 15 minutes after the end. I was able to marry my partner. founder Dotan Asselmann – who was pc’s vision assistant in 8100 [an elite unit of the Israel Defense Forces].
Theator, which raised $3 million in initial investment in April 2019, operates a business-to-business model. Aimed at a usable market of $6. 2 billion to minimize the headaches of general surgery, Theator partners with so-called tour providers, who record surgical videos. Corporate fees for general surgeons, gynecologists, urologists and others are charged per month or per shift. Lately, the tador is carrying out pilot projects with pioneers such as leading professional companies, McGill University and others.
StuffThatWorks voices drug development
At Waze, Elish has solved a major marketing problem: achieving a critical mass of users eager to provide accurate and timely reports on road conditions. As he explained in an interview on September 3, “How are other people asked to register and make a contribution [to a crowdsourcing site when it is too small to offer] value?You’ll have to be very professional. Users deserve to be proud to make a contribution to the realization of vision and registration for value creation. It’s an expectations definition query: it will take a year or two to add more value. »
STW was presented as a solution to an elish challenge. “While working at Google after the acquisition of waze, my daughter suffered from a chronic illness. This didn’t have to be deadly. It caused suffering in the circle of relatives so to speak worse. I searched frantically online every night for a clear idea. There’s going to have to be something out there: a teenage blog post. Finally, I discovered a remedy in Israel, taking it and in three weeks [his symptoms] disappeared. “
STW aims to focus the innovation program of medical and pharmaceutical generation corporations more directly on patient outcomes. “There are 10,000 chronic diseases affecting 6. 5 billion other people worldwide and the stage is getting worse. What happens to those patients. Anyone with cash, such as pharmaceutical corporations, focuses on a subset of patients with no data on what works. There is no comparison between methods. We are collaborating to gather real-world evidence that works for patients,” Elish said.
STW has been running stealthily for two years. In July 2020, it raised $9 million, according to TechCrunch. He met more than a hundred other conditions, out of 220,000 participants, with 12 million knowledge points, Elish said.
Elish left Google and co-founded STW with two others. According to TechCrunch, among them was technology director Ron Held, a “trained mathematician and former head of an IDF intelligence team,” and leading knowledge scientist Yossi Synett, who is “an expert in learning, AI and practical analysis devices. “»
STW is helping patients and medical researchers. It allows patients to express their fears and percentage recommendations on effective and useless treatments. It also provides the patient’s voice in the procedure for upcoming treatments for the disease.
As Dr. Amir Tirosh, Director of the Division of Endocrinology, Diabetes and Metabolism at Sheba Hospital – Tel Ha Shomer and Assistant Professor at Harvard Medical School, told me on September 15: “[As Chair of the STW Subcommittee on Diabetes Type 1] I’m very happy that Yael is using the new social media to break a taboo in the industry. Allowing patients to tell us what they think is important. Pharmaceutical corporations control drugs as opposed to a placebo because regulators do so. But this leaves many unanswered questions about efficacy, appearance effects and additional approaches. “
Scientists in the STW databases view the express symptoms of disease in the context of the environmental intellectual points that cause the disease and in relation to other situations. Tirosh said: “STW databases allow medical science to map tens of thousands of patients around the world with weather maps, air pollutants and other physical and intellectual situations. For example, polycystic ovary syndrome is a condition with physical symptoms, such as increased hair expansion and the threat of diabetes, as well as intellectual situations, such as depression and anxiety, Tirosh explained.
Israel’s virtual fitness industry aims to solve patient pain. The existing pandemic makes the need for such responses urgent. These corporations can offer exciting acquisition opportunities for established operators eager to grow.
I left U. S. corporations in 1994 and established a risk capital and control consulting firm (http://petercohan. com). I followed the movements of 1981 when I was
I left U. S. corporations in 1994 and established a risk capital and control consulting firm (http://petercohan. com). I started tracking movements in 1981 when I was at MIT High School and first analyzed generational movements as a guest at CNBC in 1998. I became a Forbes contributor in April 2011. My fourteenth eBook, published in February 2019, is “Scale your startup: master the four steps of the $10 billion idea. “I gave the impression 8 times in the 2016 documentary “We The People: The Market Basket Effect” (http://www. themarketbasketeffect. com/). I also teach corporate strategy and entrepreneurship at Babson College in Wellesley, Massachusetts (http://www. babson. edu/Academics/faculty/profiles/Pages/Cohan-Peter. aspx)